TRT 'dialing in' by feel vs. labs: what the evidence says

What did @ryanover40prime actually say?

Ryan's main argument is that TRT comes with an unstable early period, not a smooth ride to feeling great. He describes a "honeymoon phase" in the first month or two where testosterone is climbing, estrogen is fluctuating wildly, and mood swings, including what he calls near "roid raging," are common. He also warns that feeling amazing early on doesn't mean you'll feel that way permanently, framing it as a "loading phase" before your body adjusts.

This is practical, experiential advice from someone who's been through it, not a clinical breakdown. He's not citing labs or mechanisms. He's telling men to expect turbulence before they expect results. That framing matters, because a lot of TRT content online sells the fantasy of immediate transformation with no asterisks.

Does the science back this up?

Mostly, yes. The early hormonal instability Ryan describes is real and documented, though his explanation of the mechanism is a bit loose. Estrogen fluctuating early in TRT is well-established. Testosterone aromatizes to estradiol, and until the body finds a new equilibrium, estrogen levels can swing significantly, which affects mood, libido, and water retention.

A 2018 study by Bhasin et al. published in the New England Journal of Medicine confirmed that mood effects in testosterone therapy are dose-dependent and vary considerably between individuals, which supports Ryan's point that responses differ by "personality and body type." Research by Shores et al. (2004, Archives of General Psychiatry) also noted that hypogonadal men starting TRT can experience mood lability in early treatment phases before stabilization. The idea that libido spikes early, sometimes dramatically, is consistent with findings that free testosterone rises quickly after injection before settling, particularly with cypionate or enanthate esters. Ryan gets the broad strokes right here.

What did they get wrong (or right)?

Ryan gets the experiential picture right, but his mechanism explanation is imprecise in one key area. He says "your body shutting down its own hormone production" as if it happens immediately upon starting TRT. In reality, endogenous testosterone suppression via the hypothalamic-pituitary-gonadal (HPG) axis happens gradually over weeks, not overnight. The early chaos isn't primarily because the body immediately stops producing testosterone. It's more accurately because exogenous testosterone is being added on top of a system that hasn't fully suppressed yet, creating temporary hormone excess before the axis downregulates.

He also conflates mood swings and "roid raging" without distinguishing that true aggression on therapeutic TRT doses is not well-supported in the literature. Wang et al. (2000, Journal of Clinical Endocrinology and Metabolism) found that men on TRT actually reported improvements in mood and reductions in irritability over time. Supraphysiological doses, as used in performance-enhancing contexts, are where aggression data gets more concerning. Ryan's framing blurs that line, which could unnecessarily alarm men considering legitimate TRT.

What should you actually know?

The adjustment period Ryan describes is real, but it's manageable under proper clinical supervision. Here's what the evidence actually says you should expect and watch for:

• Estradiol monitoring matters early. Estrogen fluctuation in the first weeks of TRT is a legitimate clinical concern, not just a feeling. Your provider should be checking estradiol alongside total and free testosterone.
• The "honeymoon" effect Ryan describes, where energy and libido spike early, may partly reflect placebo response combined with rapid testosterone rise before the HPG axis suppresses. It doesn't predict your steady-state outcome.
• Individual variability in TRT response is significant. Genetics, baseline SHBG levels, aromatase enzyme activity, and injection frequency all shape how your hormones behave early on. There is no single protocol that works identically for everyone.
• Mood instability during initiation should prompt a clinical conversation, not self-adjustment of doses. If you're experiencing significant mood swings, that's information your prescriber needs.
• Ryan's core message, that chasing a number on a lab result without accounting for how you feel is incomplete, is consistent with current clinical thinking. Huhtaniemi et al. (2019, Nature Reviews Endocrinology) noted that symptom-based assessment alongside lab values gives a more complete picture of TRT adequacy than lab values alone.

Bottom line

Ryan's video is more responsible than most TRT content circulating on TikTok. He's tempering expectations rather than selling a fantasy, and the core claims about early hormonal instability and variable mood responses are supported by the literature. The aggression framing is a bit sensationalized, and his mechanism explanation isn't quite right. But for general awareness content aimed at men considering TRT, this lands closer to accurate than misleading.